Ligand Pharmaceuticals | Efectivo Y Equivalentes



Cash And Equivalent Cambio Fecha
Amgen USD 11.97B 2.96B 2024-12
Arrowhead Research USD 51.79M 47.4M 2024-12
Baxter International USD 1.76B 344M 2024-12
Bristol-Myers Squibb USD 10.35B 2.46B 2024-12
Eli Lilly USD 3.27B 100.6M 2024-12
Gilead Sciences USD 9.99B 4.95B 2024-12
GlaxoSmithKline GBP 3.87B 678M 2024-12
Glaxosmithkline GBP 3.87B 678M 2024-12
Insmed USD 555.03M 93.58M 2024-12
Ionis Pharmaceuticals USD 242.08M 92.53M 2024-12
Ligand Pharmaceuticals USD 72.31M 8.69M 2024-12
MacroGenics USD 182.84M 3.22M 2024-12
Merck USD 13.24B 1.35B 2024-12
Pacira USD 276.77M 30.81M 2024-12
Pfizer USD 1.04B 49M 2024-12
Veracyte USD 239.09M 34.99M 2024-12



Ligand Pharmaceuticals Efectivo Y Equivalentes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.